Medical Instrument Compatible Disinfectant Generator
医疗器械兼容消毒剂发生器
基本信息
- 批准号:7493579
- 负责人:
- 金额:$ 44.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-15 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:Acetic AcidAcetic AcidsAcidsAddressAluminumAnimalsAwardBackBacteriaBacterial SporesBenignBiocideBiological PreservationBreathingCapitalCaringCellsChemicalsChlorineCitric AcidCollaborationsColonoscopesCommunitiesCompatibleConditionConstruction MaterialsConsultationsCorrosionCorrosivesCross InfectionCustomCystDataDetectionDevelopmentDevicesDiagnostic ProcedureDisinfectantsDisinfectionDoseDropsDrug FormulationsEffectivenessElectrolysesEmerging TechnologiesEmulsionsEndoscopesEnvironmentEquilibriumEquipmentEthylene OxideEvaluationExcisionExposure toFacility Construction Funding CategoryFoodFoundationsFrequenciesFundingGasesGenerationsGermicideGlutaralGoalsGovernmentHealthHealth ProfessionalHigh temperature of physical objectHospitalsHourHumanHydrocarbonsHydrogen PeroxideHydrolysisHypochloriteHypochlorous AcidHypochlorous AcidsHysteroscopesIn SituIndustrial fungicideIndustryInterventionInvasiveInvestmentsIrritantsJointsLaparoscopesLegal patentLettersLicensingLifeLiquid substanceMaintenanceManufacturer NameMarketingMaterials TestingMeasuresMedicalMedical DeviceMedical centerMedicineMembraneMetabolicMethodsMicrobeMicrobial BiofilmsMonitorMotivationNamesNumbersOperating SystemOperative Surgical ProceduresOxidantsParentsPatientsPeracetic AcidPerformancePeroxidesPersonsPhasePhase I Clinical TrialsPoisonPowder dose formPreparationProceduresProcessProductionPropertyPublicationsPurposeRangeRateReproduction sporesResearchResearch PersonnelResistanceSafetySaltsSodium ChlorideSodium HypochloriteSolutionsSterilization for infection controlSteriloxSurgical InstrumentsSystemTechniquesTechnologyTest ResultTestingTexasTimeToxic effectToxinTransportationUltrasonicsUnited States Environmental Protection AgencyUnited States Food and Drug AdministrationUniversitiesVirusWaterWater PurificationWorkantimicrobialaqueousbacterial resistancebactericidebasechlorine dioxidecommercializationconceptcostcost effectivedesigndesiredetectordirect applicationdisease transmissiondosagefood preparationfood sanitationfungushazardinhibitor/antagonistinnovationinstrumentinterestkillingsmedical foodmedical schoolsmicrobialmicroorganismnew technologynoveloccupational hazardpressurepreventprototypeskillssodium chloritesodium sulfatesuccesssuperoxidized watertechnology developmenttrenduser-friendlyvaporvirucide
项目摘要
DESCRIPTION (provided by applicant): Lynntech, Inc in collaboration with a reputed medical school proposes the development of an automated, on- demand, electrochemical generator of chlorine dioxide for a variety of high level disinfection applications, including endoscope reprocessing and surgical instrument disinfection. During the Phase I project, Lynntech has already demonstrated the construction and reliable operation of a bench scale automated device which can deliver desired levels of chlorine dioxide in a rapid manner. Lynntech's electrochemically generated chlorine dioxide solutions have been demonstrated to be as effective a disinfectant as commercially available presently used peracetic acid based high level disinfectants. In addition, Lynntech's electrochemically generated chlorine dioxide solutions have been shown to be compatible with a wide variety of medically relevant materials, and in certain cases, significantly less corrosive to medical materials than the widely used peracetic acid based disinfectants. Since complete proof-of-concept for Lynntech's automated electrochemical chlorine dioxide generator has been provided in the Phase I project, this proposed follow on Phase II effort specifically aims to develop a prototype compact device for automated medical device (endoscopes and surgical instruments) reprocessing. The device proposed herein will be fabricated, automated and tested upon retrofitting to a commercially available automated endoscope reprocessor for reliable operation in consultation with a reputed medical school. We will also perform exhaustive testing of the efficacy of the chlorine dioxide generator for low corrosion disinfection of actual surgical instruments and endoscopes during this Phase II effort. We will showcase our device and its operation to large manufacturers of automated endoscope reprocessors. Based on their input we will gear the technology to be commercially attractive to facilitate commercialization beyond Phase II in collaboration with these manufacturers, through either joint development, spin off company formation or outright licensing scenarios. The development of our low cost, fast acting and safe automated chlorine dioxide generator based automated reprocessor device will enable the production of high performance disinfecting solution for reliable medical instrument reprocessing. This will certainly reduce health professional exposure to toxic chemicals and decrease the cost of medical instrument reprocessing. In addition, the hundreds of thousands of patients who undergo endoscopic or surgical procedures annually will be adequately protected against cross infection through the availability of our automated medical instrument reprocessor. The financial benefits to existing automated reprocessing unit manufacturers who can simply modify their existing devices to incorporate the electrochemical chlorine dioxide production technology will therefore be immense.
描述(由申请人提供):Lynntech, Inc 与一所知名医学院合作,提议开发一种自动化、按需、电化学二氧化氯发生器,用于各种高水平消毒应用,包括内窥镜再处理和手术器械消毒。在第一阶段项目中,Lynntech 已经展示了小型自动化设备的构造和可靠运行,该设备可以快速提供所需水平的二氧化氯。 Lynntech 的电化学产生的二氧化氯溶液已被证明是与市售目前使用的基于过乙酸的高水平消毒剂一样有效的消毒剂。此外,Lynntech 的电化学产生的二氧化氯溶液已被证明与多种医疗相关材料兼容,并且在某些情况下,对医疗材料的腐蚀性明显低于广泛使用的过氧乙酸消毒剂。由于第一阶段项目已经提供了 Lynntech 自动化电化学二氧化氯发生器的完整概念验证,因此拟议的第二阶段工作具体目标是开发用于自动化医疗设备(内窥镜和手术器械)再处理的原型紧凑设备。本文提出的装置将在改装为市售自动内窥镜清洗机后进行制造、自动化和测试,以便与知名医学院协商进行可靠操作。在第二阶段工作中,我们还将对二氧化氯发生器对实际手术器械和内窥镜进行低腐蚀消毒的功效进行详尽的测试。我们将向自动化内窥镜清洗机的大型制造商展示我们的设备及其操作。根据他们的意见,我们将与这些制造商合作,通过联合开发、分拆公司组建或直接许可方案,使该技术具有商业吸引力,以促进第二阶段之后的商业化。我们开发的低成本、快速作用且安全的基于自动二氧化氯发生器的自动再处理设备将能够生产用于可靠的医疗器械再处理的高性能消毒溶液。这肯定会减少卫生专业人员接触有毒化学品的机会,并降低医疗器械再处理的成本。此外,通过我们的自动化医疗器械再处理机,每年接受内窥镜或外科手术的数十万患者将得到充分保护,免受交叉感染。因此,现有的自动化后处理装置制造商可以简单地修改其现有设备以纳入电化学二氧化氯生产技术,从而获得巨大的经济效益。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANJAL C SHARMA其他文献
ANJAL C SHARMA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANJAL C SHARMA', 18)}}的其他基金
iKITT Innovative Keratitis Identity Type Test
iKITT 创新角膜炎身份类型测试
- 批准号:
10007570 - 财政年份:2020
- 资助金额:
$ 44.95万 - 项目类别:
iKITT Innovative Keratitis Identity Type Test
iKITT 创新角膜炎身份类型测试
- 批准号:
10259811 - 财政年份:2020
- 资助金额:
$ 44.95万 - 项目类别:
iCAP An Innovative Device to Rapidly Resolve Microbial Keratitis
iCAP 一种快速解决微生物性角膜炎的创新设备
- 批准号:
10253311 - 财政年份:2016
- 资助金额:
$ 44.95万 - 项目类别:
iCAP An Innovative Device to Rapidly Resolve Microbial Keratitis
iCAP 一种快速解决微生物性角膜炎的创新设备
- 批准号:
9135879 - 财政年份:2016
- 资助金额:
$ 44.95万 - 项目类别:
iCAP An Innovative Device to Rapidly Resolve Microbial Keratitis
iCAP 一种快速解决微生物性角膜炎的创新设备
- 批准号:
10412137 - 财政年份:2016
- 资助金额:
$ 44.95万 - 项目类别:
iCAP An Innovative Device to Rapidly Resolve Microbial Keratitis
iCAP 一种快速解决微生物性角膜炎的创新设备
- 批准号:
10621935 - 财政年份:2016
- 资助金额:
$ 44.95万 - 项目类别:
Arrayed Lateral Flow Biosensor for Rapid Molecular Identification of UTI-Related
用于尿路感染相关快速分子鉴定的阵列侧流生物传感器
- 批准号:
8393124 - 财政年份:2012
- 资助金额:
$ 44.95万 - 项目类别:
Contractile Hydrogel Dressing for Primary Wound Closure
用于闭合原发伤口的收缩性水凝胶敷料
- 批准号:
8000269 - 财政年份:2010
- 资助金额:
$ 44.95万 - 项目类别:
Stimuli Responsive Topical Gels for Mechanically Assisted Wound Debridement
用于机械辅助伤口清创的刺激响应局部凝胶
- 批准号:
8057532 - 财政年份:2010
- 资助金额:
$ 44.95万 - 项目类别:
Medical Instrument Compatible Disinfectant Generator
医疗器械兼容消毒剂发生器
- 批准号:
7326234 - 财政年份:2007
- 资助金额:
$ 44.95万 - 项目类别:
相似国自然基金
乙酸干扰西瓜嗜酸菌生物膜形成作用机制的研究
- 批准号:32360695
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
小热休克蛋白Hsp26调控K.marxianus发酵米酸汤高产乙酸乙酯机理研究
- 批准号:32360568
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
大红浙醋酿造环境中乙醇和乙酸诱导酸居芽孢杆菌生成芳香味直链醛的分子机制
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
整合多组学解析NaHSO3降低产琥珀酸放线杆菌丁二酸发酵副产物乙酸形成的分子机制
- 批准号:
- 批准年份:2020
- 资助金额:34 万元
- 项目类别:地区科学基金项目
低温对Pichia kudriavzevii发酵小麦粉酸面团富集乙酸-2-苯乙酯的机制研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
相似海外基金
Low-cost integrated nucleic acid amplification testing platform for cervical cancer screening in low- and middle-income countries
用于低收入和中等收入国家宫颈癌筛查的低成本综合核酸扩增检测平台
- 批准号:
10678488 - 财政年份:2023
- 资助金额:
$ 44.95万 - 项目类别:
Reverse Metabolomics for the Discovery of Disease Associated Microbial Molecules
用于发现疾病相关微生物分子的反向代谢组学
- 批准号:
10651361 - 财政年份:2023
- 资助金额:
$ 44.95万 - 项目类别:
Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach
通过集成 CRISPR 和荧光核酸方法将 CODA 应用于宫颈癌筛查
- 批准号:
10647930 - 财政年份:2023
- 资助金额:
$ 44.95万 - 项目类别:
Fluoride-Mediated Desilylative Radiosynthesis of 11C-Labeled PET Tracers
氟化物介导的 11C 标记 PET 示踪剂的脱甲硅烷基放射合成
- 批准号:
10610450 - 财政年份:2022
- 资助金额:
$ 44.95万 - 项目类别:
Short-chain fatty acids and chronic temporomandibular joint pain
短链脂肪酸与慢性颞下颌关节疼痛
- 批准号:
10545725 - 财政年份:2022
- 资助金额:
$ 44.95万 - 项目类别: